Evidence map

ArticleJournal of diabetes investigation2019

Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post-marketing surveillance study in Japan.

Soulmaz Fazeli Farsani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30667173